Related Experiment Video
Updated: May 24, 2025
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Progressive Anatomical Evolution Leading to Loss of S-ICD Eligibility in Hypertrophic Cardiomyopathy: A Case Report
Luca Avolio1, Paolo Zappulla1, Daniela Dugo1
1Department of Cardiology, A.O.U. Policlinico "Gaspare Rodolico - San Marco", Catania, Italy.
Insights
Hypertrophic cardiomyopathy (HCM) progression can lead to subcutaneous implantable cardioverter defibrillator (S-ICD) ineligibility over time. Periodic reassessment is crucial for patients with HCM to ensure continued S-ICD suitability.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Subcutaneous implantable cardioverter defibrillators (S-ICDs) offer an alternative to transvenous leads, aiming to reduce lead-related complications.
- Patient selection for S-ICD is critical, particularly in hypertrophic cardiomyopathy (HCM) patients who often present with conduction abnormalities.
Abstract:
Subcutaneous implantable cardioverter defibrillators (S-ICDs) are designed to avoid complications from transvenous leads, but patient selection requires careful screening, especially in conditions like hypertrophic cardiomyopathy (HCM) with frequent conduction abnormalities. A 27-year-old male with HCM underwent S-ICD implantation in 2015 after successful screening. In 2020, inappropriate shocks due to T-wave oversensing led to vector adjustments. By 2022, further shocks and failed re-screening revealed ineligibility for S-ICD due to low R/T ratios in multiple vectors. Imaging and ECG comparisons from 2015 to 2022 showed disease progression, with increased fibrosis and conduction abnormalities. As a result, a transvenous ICD was implanted. This case underscores how HCM progression, associated with fibrosis and ECG changes, can render S-ICD unsuitable over time. It highlights the importance of periodic reassessment in high-risk patients, as disease progression can compromise S-ICD eligibility, necessitating alternative solutions for inappropriate shocks.
